Skip to main content
TGV SRAAC LIMITED logo

TGV SRAAC LIMITED — Investor Relations & Filings

Ticker · 507753 ISIN · INE284B01028 LEI · 335800FLU23CBP4Z5A31 BSE.NS Manufacturing
Filings indexed 483 across all filing types
Latest filing 2023-01-30 Regulatory Filings
Country IN India
Listing BSE.NS 507753

About TGV SRAAC LIMITED

https://www.tgvgroup.com

TGV SRAAC Limited is a diversified manufacturing enterprise specializing in the production of Chlor-Alkali products and fatty acids. The company's core operations center on the manufacture of Caustic Soda, Liquid Chlorine, Hydrochloric Acid, and Sodium Hypochlorite. It also produces Potassium Hydroxide and Chloromethanes, including Methylene Chloride and Chloroform. Beyond its inorganic chemical portfolio, the firm maintains a significant presence in the oleochemicals segment, producing Stearic Acid, Soap Noodles, and refined Glycerin. Utilizing advanced membrane cell technology, the company ensures high-purity output for applications in water treatment, textiles, paper manufacturing, and the pharmaceutical sector. Integrated captive power generation facilities support its energy-intensive electrolytic processes, enhancing operational efficiency and cost-competitiveness.

Recent filings

Filing Released Lang Actions
TGV Sraac Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve Un-audited finanical results for ....
Regulatory Filings Classification · 95% confidence The document is a notice from TGV SRAAC Limited addressed to BSE Limited regarding a Board Meeting scheduled to consider and take on record the Un-audited Financial Results for the Third Quarter/Nine Months ended 31.12.2022. It references Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to disclosure of financial results. The document is short (2407 characters) and serves as an announcement of the upcoming board meeting and the financial results consideration, not the financial results report itself. It does not contain actual financial data or detailed financial statements. Therefore, it is an announcement related to financial results, fitting the category of Regulatory Filings (RNS) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2023-01-30 English
Submission of Information regarding Issue of Duplicate Share Certificates to our shareholders in lieu thereof under Regulation 39(3) of the SEBI (LODR) Regulations, 2015.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the BSE Limited regarding the issuance of duplicate share certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details of shareholders and the duplicate share certificates issued. This is a regulatory compliance communication related to share certificates and does not contain financial statements, management discussion, or other report content. It is not an announcement of voting results, capital changes, or insider dealings. The document is a regulatory filing informing the stock exchange about share certificate issuance, fitting best under Regulatory Filings (RNS). The document length is short and focused on compliance information rather than a report or announcement of a report.
2023-01-10 English
Submission of Compliance certificate under Reg.74(5) of SEBI (DP) Reg.2018 for quarter ending 31.12.2022.
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, certifying actions related to dematerialization of securities for the quarter ending 31.12.2022. It is addressed to the stock exchange and confirms compliance with regulatory requirements. The document is short (3644 characters) and primarily serves as a certification letter rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or other report content. Therefore, it fits the category of Regulatory Filings (RNS), which includes officer certifications and compliance confirmations.
2023-01-09 English
Intimation regarding Loss of Share Certificates received from our RTA M/s Aarthi Consultants Pvt Ltd., and Issue of Duplicate Share Certificates in lieu thereof under Regulation 39(3) ....
Regulatory Filings Classification · 100% confidence The document is a letter addressed to BSE Limited regarding the loss of share certificates and the issuance of duplicate share certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains details of shareholders and their lost certificates, requesting the stock exchange to take the information on record. This is a regulatory compliance announcement related to share certificate management and does not contain financial results, management discussion, or other report content. It is not a financial report, earnings release, or management information. It is a regulatory filing informing the exchange about a specific compliance matter.
2022-12-29 English
Intimation of closure of Trading Window.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange secretary informing about the closure of the trading window for insiders due to the upcoming board meeting to consider the unaudited financial results for the third quarter ended December 31, 2022. It references SEBI regulations on insider trading and specifies the trading window closure period. The document does not contain any financial statements, detailed financial data, or the actual financial results. It is a regulatory announcement related to compliance and trading restrictions ahead of financial results disclosure. The document length is short (1600 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-12-28 English
The Board of Directors in its meeting held on 02.12.2022 have approved the proposal of the company to expand its Caustic Soda capacity by 270 MTs and related Liquid Chlorine etc., products ....
Regulatory Filings
2022-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.